156 related articles for article (PubMed ID: 36121713)
1. MicroRNAs, Key Regulators in Glioma Progression as Potential Therapeutic Targets for Chinese Medicine.
Fan H; Xie X; Kuang X; Du J; Peng F
Am J Chin Med; 2022; 50(7):1799-1825. PubMed ID: 36121713
[TBL] [Abstract][Full Text] [Related]
2. MSC-AS1 knockdown inhibits cell growth and temozolomide resistance by regulating miR-373-3p/CPEB4 axis in glioma through PI3K/Akt pathway.
Li C; Feng S; Chen L
Mol Cell Biochem; 2021 Feb; 476(2):699-713. PubMed ID: 33106913
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-144 represses gliomas progression and elevates susceptibility to Temozolomide by targeting CAV2 and FGF7.
Liu ZQ; Ren JJ; Zhao JL; Zang J; Long QF; Du JJ; Jia XT; Gu NB; Di ZL; Qian YH; Li SZ
Sci Rep; 2020 Mar; 10(1):4155. PubMed ID: 32139705
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of circHIPK3 Facilitates Temozolomide Sensitivity in Glioma by Regulating Cellular Behaviors Through miR-524-5p/KIF2A-Mediated PI3K/AKT Pathway.
Yin H; Cui X
Cancer Biother Radiopharm; 2021 Sep; 36(7):556-567. PubMed ID: 32833501
[No Abstract] [Full Text] [Related]
5. MicroRNAs involved in chemo- and radioresistance of high-grade gliomas.
Besse A; Sana J; Fadrus P; Slaby O
Tumour Biol; 2013 Aug; 34(4):1969-78. PubMed ID: 23568705
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-155-3p promotes glioma progression and temozolomide resistance by targeting Six1.
Chen G; Chen Z; Zhao H
J Cell Mol Med; 2020 May; 24(9):5363-5374. PubMed ID: 32220051
[TBL] [Abstract][Full Text] [Related]
7. miR-93 promotes cell proliferation in gliomas through activation of PI3K/Akt signaling pathway.
Jiang L; Wang C; Lei F; Zhang L; Zhang X; Liu A; Wu G; Zhu J; Song L
Oncotarget; 2015 Apr; 6(10):8286-99. PubMed ID: 25823655
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of miR-196b Promotes Glioma Cell Sensitivity to Temozolomide Chemotherapy and Radiotherapy.
Ma R; Zheng G; Shao C; Liu J; Lv H; Zhang G
Ann Clin Lab Sci; 2018 Nov; 48(6):719-725. PubMed ID: 30610041
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs involved in the EGFR/PTEN/AKT pathway in gliomas.
Wang Y; Wang X; Zhang J; Sun G; Luo H; Kang C; Pu P; Jiang T; Liu N; You Y
J Neurooncol; 2012 Jan; 106(2):217-24. PubMed ID: 21842313
[TBL] [Abstract][Full Text] [Related]
10. The Mechanisms of Current Platinum Anticancer Drug Resistance in the Glioma.
Lu E; Gareev I; Yuan C; Liang Y; Sun J; Chen X; Beylerli O; Sufianov A; Zhao S; Yang G
Curr Pharm Des; 2022; 28(23):1863-1869. PubMed ID: 35674307
[TBL] [Abstract][Full Text] [Related]
11. Salvianolic acid A (Sal A) suppresses malignant progression of glioma and enhances temozolomide (TMZ) sensitivity via repressing transgelin-2 (TAGLN2) mediated phosphatidylinositol-3-kinase (PI3K) / protein kinase B (Akt) pathway.
Ye T; Chen R; Zhou Y; Zhang J; Zhang Z; Wei H; Xu Y; Wang Y; Zhang Y
Bioengineered; 2022 May; 13(5):11646-11655. PubMed ID: 35505656
[TBL] [Abstract][Full Text] [Related]
12. MiR-16-5p is frequently down-regulated in astrocytic gliomas and modulates glioma cell proliferation, apoptosis and response to cytotoxic therapy.
Krell A; Wolter M; Stojcheva N; Hertler C; Liesenberg F; Zapatka M; Weller M; Malzkorn B; Reifenberger G
Neuropathol Appl Neurobiol; 2019 Aug; 45(5):441-458. PubMed ID: 30548945
[TBL] [Abstract][Full Text] [Related]
13. miR-489 inhibits proliferation, cell cycle progression and induces apoptosis of glioma cells via targeting SPIN1-mediated PI3K/AKT pathway.
Li Y; Ma X; Wang Y; Li G
Biomed Pharmacother; 2017 Sep; 93():435-443. PubMed ID: 28666210
[TBL] [Abstract][Full Text] [Related]
14. MiR-3116 sensitizes glioma cells to temozolomide by targeting FGFR1 and regulating the FGFR1/PI3K/AKT pathway.
Kong S; Cao Y; Li X; Li Z; Xin Y; Meng Y
J Cell Mol Med; 2020 Apr; 24(8):4677-4686. PubMed ID: 32181582
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol inhibits glioma cell growth via targeting oncogenic microRNAs and multiple signaling pathways.
Wang G; Dai F; Yu K; Jia Z; Zhang A; Huang Q; Kang C; Jiang H; Pu P
Int J Oncol; 2015 Apr; 46(4):1739-47. PubMed ID: 25646654
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of circular RNA CEP128 suppresses proliferation and improves cytotoxic efficacy of temozolomide in glioma cells by regulating miR-145-5p.
Hua L; Huang L; Zhang X; Feng H; Shen B
Neuroreport; 2019 Dec; 30(18):1231-1238. PubMed ID: 31599823
[TBL] [Abstract][Full Text] [Related]
17. Methylation associated miR-1246 contributes to poor prognosis in gliomas treated with temozolomide.
Wang H; Wu B; Wang J; Hu Y; Dai X; Ye L; Cheng H
Clin Neurol Neurosurg; 2021 Jan; 200():106344. PubMed ID: 33153768
[TBL] [Abstract][Full Text] [Related]
18. miR-149 rs2292832 C allele enhances the cytotoxic effect of temozolomide against glioma cells.
Xu B; Luo X; Ning X; Luo J; Guo J; Liu Q; Ling G
Neuroreport; 2020 Apr; 31(6):498-506. PubMed ID: 32243354
[TBL] [Abstract][Full Text] [Related]
19. ZNF300 enhances temozolomide resistance in gliomas by regulating lncRNA SNHG12.
Fu J; Peng J; Tu G
Gen Physiol Biophys; 2022 Jul; 41(4):349-355. PubMed ID: 35938968
[TBL] [Abstract][Full Text] [Related]
20. miR-139 Functions as An Antioncomir to Repress Glioma Progression Through Targeting IGF-1 R, AMY-1, and PGC-1β.
Wang H; Yan X; Ji LY; Ji XT; Wang P; Guo SW; Li SZ
Technol Cancer Res Treat; 2017 Aug; 16(4):497-511. PubMed ID: 26868851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
